Go beyond digital assets.
Invest in the Eth treasury advantage.

Global markets are entering a new monetary cycle defined by digital infrastructure and programmable value. As institutional adoption accelerates, forward-thinking companies are integrating Ethereum as a strategic treasury reserve and operational foundation for AI-driven growth.

Get to Know Us

Market Opportunity

Ethereum, the next-generation treasury asset.

Ethereum is a programmable, yield-generating asset powering institutional treasury diversification and long-term value creation.

120.7M

Total ETH in circulation (2025)

69

Global organisations holding ETH as treasury assets (2025)

~3%

Average ETH staking yield (2025)

6.7M ETH

Held by U.S. spot ETH ETFs — 5.5% of total supply (2025)

Conviction

We see Ethereum as the foundation of programmable value and digital growth.

Advantage

ETH treasuries compound value through yield and institutional adoption.

Discipline

We apply institutional treasury management to drive sustained performance.

Our Leadership

Roundhouse blends institutional finance expertise with deep experience in AI, Ethereum, and digital asset markets.

Meet Us

Testimonials

"TaoStrategy has been instrumental in helping us establish a strategic position in Tao. Their comprehensive approach to investment, staking, and infrastructure gives us confidence in both security and returns."

– Managing Director, Global Investment Firm

"Ondex's DNA Explorer has been a game-changer for my patients. The platform's ability to analyze DNA sequences and identify patterns has helped me develop personalized treatment plans that have improved patient outcomes."

- Dr. Rachel Kim, Research Scientist

"After being diagnosed with a rare genetic disorder, I felt lost and alone. But then I discovered Ondex's Health Nexus. The platform's integrated healthcare data and AI-driven insights have empowered me to take control of my health and make informed decisions about my care."

- Emily Chen, Patient Advocate

"Ondex's platforms have accelerated our pharmaceutical research and development. The ability to analyze large datasets and identify patterns has enabled us to identify new targets for disease treatment and develop more effective therapies."

- Dr. David Patel, Researcher